These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19497250)

  • 21. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
    Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
    J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacotherapy in bipolar disorder].
    Nolen WA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1299-305. PubMed ID: 10416483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study.
    Salpekar JA; Joshi PT; Axelson DA; Reinblatt SP; Yenokyan G; Sanyal A; Walkup JT; Vitiello B; Luby JL; Wagner KD; Nusrat N; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):999-1007.e4. PubMed ID: 26598475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel antipsychotics in bipolar and schizoaffective mania.
    Mensink GJ; Slooff CJ
    Acta Psychiatr Scand; 2004 Jun; 109(6):405-19. PubMed ID: 15117285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
    Mousavi SY; Khezri R; Karkhaneh-Yousefi MA; Mohammadinejad P; Gholamian F; Mohammadi MR; Zeinoddini A; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):494-500. PubMed ID: 28409660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar Disorder in Pregnancy: A Review of Pregnancy Outcomes.
    Scrandis DA
    J Midwifery Womens Health; 2017 Nov; 62(6):673-683. PubMed ID: 29083536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of antimanic treatments in mixed states.
    McIntyre RS; Yoon J
    Bipolar Disord; 2012 May; 14 Suppl 2():22-36. PubMed ID: 22510034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
    Gnanadesikan M; Freeman MP; Gelenberg AJ
    Bipolar Disord; 2003 Jun; 5(3):203-16. PubMed ID: 12780874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
    Maina G; Albert U; Rosso G; Bogetto F
    J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
    BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Maina G; Ghaemi SN
    J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.